Clinical Impact of Recent Genetic Discoveries in Osteoporosis
Overview
Affiliations
Osteoporotic fracture carries an enormous public health burden in terms of mortality and morbidity. Current approaches to identify individuals at high risk for fracture are based on assessment of bone mineral density and presence of other osteoporosis risk factors. Bone mineral density and susceptibility to osteoporotic fractures are highly heritable, and over 60 loci have been robustly associated with one or both traits through genome-wide association studies carried out over the past 7 years. In this review, we discuss opportunities and challenges for incorporating these genetic discoveries into strategies to prevent osteoporotic fracture and translating new insights obtained from these discoveries into development of new therapeutic targets.
Low Bone Mineral Density in Hemophiliacs.
Gebetsberger J, Schirmer M, Wurzer W, Streif W Front Med (Lausanne). 2022; 9:794456.
PMID: 35186990 PMC: 8849249. DOI: 10.3389/fmed.2022.794456.
Toth Z, Ward A, Tang S, McBride-Gagyi S Bone. 2021; 150:116002.
PMID: 33971313 PMC: 8217247. DOI: 10.1016/j.bone.2021.116002.
Paillard T Front Physiol. 2018; 9:1035.
PMID: 30108520 PMC: 6079577. DOI: 10.3389/fphys.2018.01035.
He Z, Zhai Q, Hu M, Cao C, Wang J, Yang H J Orthop Translat. 2018; 3(1):1-11.
PMID: 30035034 PMC: 5982384. DOI: 10.1016/j.jot.2014.11.002.
Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
Xiao X, Roohani D, Wu Q Osteoporos Int. 2018; 29(8):1807-1814.
PMID: 29713799 PMC: 6093295. DOI: 10.1007/s00198-018-4546-1.